If not, with your permission, LAMMICO can report your completion of our course “Louisiana Act 76, Controlled Substances: Prescribing, Diversion Prevention and Addiction Treatment” to the Louisiana State Board of Medical Examiners (LSBME) and applicable MOC boards on your behalf.
The opioid overdose crisis has brought significant regulatory changes to how, when, and why prescribers may write opioid prescriptions. In Louisiana, new laws are in place requiring education on prescribing controlled substances to proactively curb opioid abuse:
- Each prescriber must now complete three hours of education on drug diversion, prescribers’ best practices and addiction treatment.
- The required education must be completed before license renewal in 2019 or upon initial licensure.
- This new education requirement is included in the credit hours already required by the LSBME, not in addition to the existing requirements.
This course meets the subject requirements specified by Act 76 of the Louisiana Legislature and the LSBME’s rules. In addition to meeting state requirements, this course also provides three (3) contact hours for CME, CNE, MOC, AAPA and AANP (includes pharmacology credit) and one (1) LAMMICO Risk Management Premium Discount Credit.
LAMMICO policyholders may access the course free of charge by logging in as a Member at lammico.com. Members of the LSMS who are not LAMMICO insureds may also access the course free of charge by logging in to the LSMS website at lsms.org.
Louisiana healthcare providers that are neither LAMMICO insureds nor members of the LSMS may take the course for a fee through LAMMICO’s subsidiary risk management education company, Medical Interactive Community, at medicalinteractive.net. Groups of 20 or more providers that are interested in purchasing this education at a discounted price should contact Medical Interactive at 844.923.9899 or firstname.lastname@example.org.